Instil Bio, Inc. (TIL)
NASDAQ:TIL
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -534.00K | $ 0.00 | $ 0.00 | $ -5.99M | $ 0.00 |
| Operating Income | $ -52.91M | $ -73.54M | $ -159.17M | $ -206.17M | $ -155.56M |
| EBITDA | $ -52.37M | $ -62.53M | $ -147.12M | $ -217.38M | $ -152.51M |
| Net Income | $ -71.37M | $ -74.14M | $ -156.09M | $ -223.18M | $ -156.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 76.13M | $ 113.31M | $ 150.36M | $ 260.92M | $ 454.10M |
| Total Assets | $ 203.52M | $ 263.57M | $ 325.63M | $ 482.13M | $ 609.98M |
| Total Debt | $ 85.18M | $ 86.89M | $ 86.05M | $ 79.90M | $ 0.00 |
| Net Debt | $ 78.54M | $ 78.08M | $ 76.86M | $ 36.19M | $ -37.59M |
| Total Liabilities | $ 89.66M | $ 94.13M | $ 99.80M | $ 118.52M | $ 54.78M |
| Stockholders' Equity | $ 113.87M | $ 169.44M | $ 225.83M | $ 363.61M | $ 555.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -36.62M | $ -65.70M | $ -102.69M | $ -264.75M | $ -179.97M |
| Operating Cash Flow | $ -36.62M | $ -55.70M | $ -82.03M | $ -180.16M | $ -122.14M |
| Investing Cash Flow | $ 25.48M | $ 53.97M | $ 41.13M | $ 114.54M | $ -474.40M |
| Financing Cash Flow | $ 7.29M | $ 1.75M | $ 8.08M | $ 71.89M | $ 393.16M |